ERBB2 and interstitial lung disease: While it is unclear whether incident ILD events were truly new events or simply reflected existing disease in patients with prevalent ILD, our findings from analyses that excluded these patients indicate that Black/African-American race and history of smoking are associated with increased risk of incident ILD after the initiation of HER2-directed therapies in the metastatic treatment setting.